AOD 9604 3mg

AOD 9604 peptide is a synthetic fragment derived from the C-terminal region (amino acids 177–191) of human growth hormone (hGH). It retains the fat-metabolizing properties of growth hormone but excludes its growth-promoting effects. This peptide has a molecular weight of approximately 1,817 Da and is supplied as a lyophilized powder in a 3 mg vial with ≥98% purity. It is primarily used in research focused on fat metabolism, lipid oxidation, and tissue recovery.

• High-Purity Peptide Fragment: ≥98% purity, derived from the lipolytic region of human growth hormone.

• 3 mg Vial: Supplied in a 3 mg vial, ideal for laboratory research.

• Metabolic Studies: Investigated for its role in lipid metabolism, fat oxidation, and energy expenditure.

• Tissue Repair: Explored for potential effects on tissue repair and cartilage health.

• Stable Formulation: Maintains chemical stability in lyophilized form; reconstitution recommended with sterile, pyrogen-free solvent.

• Long-Term Storage: Suitable for long-term storage under controlled conditions.

• Manufactured Under GMP-like Conditions: Produced to support laboratory reliability and reproducible research.

AOD 9604 peptide has been studied for its ability to stimulate fat metabolism through beta-3 adrenergic receptor (β3-AR) activation in adipose tissue, independent of growth hormone receptor signaling. Current research is focused on its effects on lipid metabolism, fat oxidation, and energy expenditure. It is also being investigated for tissue repair and cartilage health, though these applications are still in preclinical stages.

In clinical trials, oral AOD 9604 doses ranged from 0.25–1 mg daily, with a 12-week study showing 1 mg daily resulted in an average weight loss of 2.6 kg compared to 0.8 kg for placebo. 

In animal studies, AOD 9604 has shown a 23–216% increase in fat oxidation and >50% reduction in adipose tissue. These effects were observed under controlled research conditions and are not applicable to human use.

Store AOD 9604 peptide lyophilized at –20°C or colder. For short-term use, room temperature storage (15–25°C) is acceptable. After reconstitution, store at 2–8°C and use within 5–7 days. Avoid repeated freeze-thaw cycles.

• Use sterile technique and protective equipment when handling
• Dispose of unused material according to local regulations

References

https://www.jofem.org/index.php/jofem/article/view/157/194

https://academic.oup.com/endo/article-abstract/142/12/5182/2988749

https://pubmed.ncbi.nlm.nih.gov/11673763/

https://pubmed.ncbi.nlm.nih.gov/26275694/

Compliance Notice

This product is intended for laboratory research use only and is not approved for human or veterinary use.